Stress-activated cytokines and the heart: from adaptation to maladaptation.
about
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood LeukocytesEffect of polyethylene glycol modification of TiO₂nanoparticles on cytotoxicity and gene expressions in human cell linesRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyTAB-1 modulates intracellular localization of p38 MAP kinase and downstream signalingA novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.Enhancing or eliminating signals for cell survival to treat disease.A multivariate approach for integrating genome-wide expression data and biological knowledgeTumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18.The extracellular matrix: at the center of it all.Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis.Macrophage roles following myocardial infarctionTransmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events.The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injuryPlasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10.Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha to coactivate nuclear receptors estrogen-related receptor alpha and PPARalphaMetabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.The cardiokine story unfolds: ischemic stress-induced protein secretion in the heartCardiac failure in C5-deficient A/J mice after Candida albicans infectionCellular remodeling in heart failure disrupts K(ATP) channel-dependent stress toleranceTNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPKTACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis.The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.Association of TNFSF8 polymorphisms with peripheral neutrophil count.Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8.Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathyTNF and congestive heart failure: therapeutic possibilities.What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.Cardiopoietic programming of embryonic stem cells for tumor-free heart repairCardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activationCardiac fibroblasts: friend or foe?Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
P2860
Q26776138-0651E3D6-4D27-481A-9352-83D5A269B864Q28382980-CFF9A62E-2596-48E6-B31E-91F18C3DA91AQ28571438-5667E9D6-16CC-44AB-B764-63697864F72AQ28581551-1D60AE77-F8B1-4247-B227-D221954B7DCBQ30496163-0F8A9E14-DA39-475F-9C64-1150A814DA84Q30498584-7AF9D088-9098-455D-A4CE-1A7DEB9300F4Q31050518-74E2420C-3CED-44DB-BDBA-8EF18C53D19CQ33641786-FD23C639-07B2-44A3-B089-DC15AEF7DB0BQ33665667-D1DBA563-E04F-4B42-A019-A3B882479A5CQ33716185-54527A11-4389-483F-ADFA-1B23414C05A0Q33802153-004AB17C-65C9-424E-AF35-DF9DEE5CFF99Q33915940-409C5E74-E534-4C1F-92FC-27E349CA2326Q33962588-4C0916CB-5814-4ADD-BD4C-8EFA94E0D304Q34022068-DED3B34F-A3D1-4796-9D86-0FCC5CC2E891Q34211688-BE6B0FB3-BCAD-4838-B5AB-986E54DDA988Q34323604-29610045-BCB7-42E5-B77C-632D5D311DADQ34607833-20245D63-31CD-4D1A-80E6-4CBC1A1563EEQ34635250-1E1BB2F5-8A17-47EB-B80F-4A8A97A51908Q34809985-AEAD2218-1F8D-4BCE-8AE3-9C9D05CBA02BQ34975841-A97DA9CB-AE7E-4426-B4B4-F998A1C33069Q34986013-E4DEB713-0DF0-4976-8487-A9BD5F73961CQ34997559-E539FC96-FCCA-4B2A-888E-D064A061826EQ34997564-AACE8475-023B-4554-BC8B-D3EB6BD55834Q35071066-3B1D6D23-9E0D-4D1C-A8C6-E380735F571AQ35460930-B476E4FF-E780-45FF-856F-3BBCD7387081Q35536642-206BDAC4-0561-4CC5-B38B-05F7E3BE6349Q35543254-9A5229BA-8A3F-44C4-9F55-87D4B34ABF24Q35757568-C36237E7-882B-440A-8C48-EE06E771F1AEQ35765497-365F0CCA-B46F-495A-9A4F-03A22558C686Q35782883-2740BD90-F377-47CD-A494-B3272352E0E7Q35954625-1A1DF8E5-FEAA-4438-A544-CF3C59472C0BQ36072891-D2EE95DE-B706-49DD-8E07-E38089B9857DQ36158687-278276D5-481B-4C9B-8C2E-8EEBBF83A4E4Q36229704-F783931F-6DDC-4266-B1B5-7C8F29ECD99CQ36350919-7D3D865B-CA42-4245-BFC6-5EE864B3E8EAQ36409013-AF43EE00-6805-410B-8520-1C8C1B5C9B9EQ36450335-06B5569C-7A8C-458E-81A7-85345B684486Q36484609-C51075DF-8DF7-4F48-9CF8-E85CB494C3D1Q36677507-B5AE628F-2902-440A-9387-F77A69B6C1DFQ36732112-DAFB68D9-124E-4748-BCA1-280D6BCCCDB7
P2860
Stress-activated cytokines and the heart: from adaptation to maladaptation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@ast
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@en
type
label
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@ast
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@en
prefLabel
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@ast
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@en
P1476
Stress-activated cytokines and the heart: from adaptation to maladaptation.
@en
P304
P356
10.1146/ANNUREV.PHYSIOL.65.092101.142249
P577
2002-05-01T00:00:00Z